{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:45:54Z","timestamp":1782499554166,"version":"3.54.5"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Treatment for latent tuberculosis infection (LTBI) is important for preventing tuberculosis disease, but many patients with LTBI do not complete treatment. Patients report barriers to treatment including poor knowledge of LTBI and insufficient treatment support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a randomized trial of a 3-minute educational video for patients prescribed LTBI treatment. Adults at Kaiser Permanente Southern California prescribed LTBI treatment were randomized to receive messages with the video link (intervention) or no intervention (control). Patients were followed for up to 12 months to assess treatment initiation and completion. We also conducted a brief survey among patients who watched the video and convened a focus group among those who did not.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During 06\/2022-12\/2023, we enrolled 496 patients in the control group and 1398 patients in the intervention group, of whom 17.0% watched the video. Patient characteristics were balanced between groups. Most were prescribed rifampin (64.8%) and isoniazid (23.4%). In intention-to-treat analyses, 82.9% and 78.8% of patients in control and intervention groups, respectively, initiated treatment (relative risk (RR) 0.95 [95% confidence interval: 0.90\u20131.00]) and 41.5% and 40.1% completed treatment (RR 0.97 [0.85\u20131.09]). In per-protocol analyses, 83.1% and 86.5% initiated treatment (aRR 1.03 [0.96\u20131.11]) and 41.4% and 45.1% completed treatment (aRR 1.06 [0.88\u20131.27]). Patients reported high acceptability and few challenges watching the video. Message fatigue and nonspecific messages were reasons for not watching the video.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The LTBI video intervention was not associated with increased treatment initiation and completion in this study. Additional interventions are needed to improve patient knowledge and support LTBI treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag366","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T11:51:59Z","timestamp":1781869919000},"source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of a Brief Educational Video for Patients Prescribed Latent Tuberculosis Treatment: A Randomized Trial in the United States"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-2431","authenticated-orcid":false,"given":"Katia J","family":"Bruxvoort","sequence":"first","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Alabama at Birmingham , Birmingham, Alabama ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-3992","authenticated-orcid":false,"given":"Lei","family":"Qian","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouxin","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-9967","authenticated-orcid":false,"given":"Brigitte","family":"Spence","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6553-1772","authenticated-orcid":false,"given":"Sally","family":"Shaw","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-0002","authenticated-orcid":false,"given":"Heidi","family":"Fischer","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9469-5875","authenticated-orcid":false,"given":"Jennifer","family":"Ku","sequence":"additional","affiliation":[{"name":"Center for Integrated Health Care Research, Kaiser Permanente Hawaii , Honolulu, Hawaii ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1483-2791","authenticated-orcid":false,"given":"Bruno","family":"Lewin","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1630-5733","authenticated-orcid":false,"given":"Jacek","family":"Skarbinski","sequence":"additional","affiliation":[{"name":"Division of Research, Kaiser Permanente Northern California , Pleasanton, California ,","place":["USA"]},{"name":"Department of Infectious Diseases, Oakland Medical Center, Kaiser Permanente Northern California, Oakland , California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-8476","authenticated-orcid":false,"given":"Sara Y","family":"Tartof","sequence":"additional","affiliation":[{"name":"Division of Epidemiologic Research, Department of Research and Evaluation, Kaiser Permanente Southern California , Pasadena, California ,","place":["USA"]},{"name":"Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine , Pasadena, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"2026062613471636900_ofag366-B1","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3201\/eid2410.180716","article-title":"Simple estimates for local prevalence of latent Tuberculosis infection, United States, 2011\u20132015","volume":"24","author":"Haddad","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2026062613471636900_ofag366-B2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249012","article-title":"State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity","volume":"16","author":"Mirzazadeh","year":"2021","journal-title":"PLoS One"},{"key":"2026062613471636900_ofag366-B3"},{"key":"2026062613471636900_ofag366-B4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.livres.2021.02.001","article-title":"Clinical perspectives of isoniazid-induced liver injury","volume":"5","author":"Lei","year":"2021","journal-title":"Liver Res"},{"key":"2026062613471636900_ofag366-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent Tuberculosis infection: recommendations from the national Tuberculosis controllers association and CDC, 2020","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2026062613471636900_ofag366-B6","author":"National Society of Tuberculosis Clinicians and National Tuberculosis Coalition of America"},{"key":"2026062613471636900_ofag366-B7","doi-asserted-by":"crossref","first-page":"ofad219","DOI":"10.1093\/ofid\/ofad219","article-title":"Latent Tuberculosis infection treatment practices in two large integrated health systems in California, 2009\u20132018","volume":"10","author":"Bruxvoort","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2026062613471636900_ofag366-B8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/PHH.0000000000001711","article-title":"Patient-reported barriers to treatment initiation and completion for latent Tuberculosis infection among patients within a large integrated health care system in southern California","volume":"29","author":"Spence","year":"2023","journal-title":"J Public Health Manag Pract"},{"key":"2026062613471636900_ofag366-B9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing kaiser permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"2026062613471636900_ofag366-B10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.pec.2021.02.009","article-title":"The use of video for patient information and education: a scoping review of the variability and effectiveness of interventions","volume":"104","author":"Chatterjee","year":"2021","journal-title":"Patient Educ Couns"},{"key":"2026062613471636900_ofag366-B11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273363","article-title":"Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems","volume":"17","author":"Fischer","year":"2022","journal-title":"PLoS One"},{"key":"2026062613471636900_ofag366-B12","doi-asserted-by":"crossref","DOI":"10.2196\/58306","article-title":"The effectiveness of video animations as a tool to improve health information recall for patients: systematic review","volume":"26","author":"Hansen","year":"2024","journal-title":"J Med Internet Res"},{"key":"2026062613471636900_ofag366-B13","doi-asserted-by":"crossref","DOI":"10.2196\/41092","article-title":"Video-based educational interventions for patients with chronic illnesses: systematic review","volume":"25","author":"Deshpande","year":"2023","journal-title":"J Med Internet Res"},{"key":"2026062613471636900_ofag366-B14","doi-asserted-by":"crossref","first-page":"109388","DOI":"10.1016\/j.pec.2025.109388","article-title":"Use and effectiveness of video-based resources by pharmacists for patient education and counselling: a systematic review","volume":"142","author":"Isaacs","year":"2026","journal-title":"Patient Educ Couns"},{"key":"2026062613471636900_ofag366-B15","doi-asserted-by":"crossref","first-page":"107992","DOI":"10.1016\/j.pec.2023.107992","article-title":"Effect of patient education videos on modifying medication-related health behaviours: a systematic review using the behaviour intervention functions","volume":"117","author":"Weidmann","year":"2023","journal-title":"Patient Educ Couns"},{"key":"2026062613471636900_ofag366-B16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11606-011-1886-3","article-title":"Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications","volume":"27","author":"Lindquist","year":"2012","journal-title":"J Gen Intern Med"},{"key":"2026062613471636900_ofag366-B17","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.japh.2016.08.012","article-title":"Low-health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications","volume":"57","author":"Yeung","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2026062613471636900_ofag366-B18","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.2196\/jmir.9825","article-title":"Using video technology to increase treatment completion for patients with latent Tuberculosis infection on 3-month isoniazid and rifapentine: an implementation study","volume":"20","author":"Lam","year":"2018","journal-title":"J Med Internet Res"},{"key":"2026062613471636900_ofag366-B19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10903-017-0601-9","article-title":"Preventing Tuberculosis in a low incidence setting: evaluation of a multi-lingual, online, educational video on latent Tuberculosis","volume":"20","author":"Gao","year":"2018","journal-title":"J Immigr Minor Health"},{"key":"2026062613471636900_ofag366-B20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s10903-025-01805-8","article-title":"Using the health belief model to assess the impact of latent Tuberculosis infection health education video towards screening adoption in non-US-born persons living in California","volume":"28","author":"Ojukwu","year":"2026","journal-title":"J Immigr Minor Health"},{"key":"2026062613471636900_ofag366-B21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5588\/ijtld.19.0161","article-title":"Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar","volume":"24","author":"Reeves","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026062613471636900_ofag366-B22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag366\/68568821\/ofag366.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag366\/68568821\/ofag366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/6\/ofag366\/68568821\/ofag366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T17:47:27Z","timestamp":1782496047000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag366\/8712909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag366","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,6]]},"article-number":"ofag366"}}